Baxter International (BAX) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0718131099

Medical Devices, Infusion Systems, Pharmaceuticals, Dialysis Equipment

Baxter International Inc. is a global healthcare company that develops and provides a wide range of products to improve patient care. The company operates through four main segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care.

One of the key areas of focus for Baxter is in the development of sterile intravenous (IV) solutions, infusion systems, and devices. These products are crucial in helping healthcare professionals deliver life-saving medications and fluids to patients. Additionally, the company offers parenteral nutrition therapies, which provide essential nutrients to patients who are unable to consume food orally.

Baxter also provides a range of pharmaceutical products, including generic injectable medications. These products are used to treat a variety of conditions, from pain management to infection control. The company's surgical hemostat and sealant products are designed to help surgeons control bleeding and promote healing during surgical procedures.

In the area of healthcare technology, Baxter offers advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. The company's patient monitoring and diagnostic technologies help healthcare professionals track patient vital signs and diagnose medical conditions.

Baxter's Kidney Care segment provides a range of products and services for patients with kidney disease. This includes chronic and acute dialysis therapies, such as peritoneal dialysis (PD), hemodialysis (HD), and continuous renal replacement therapies (CRRT). The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients' homes under physician supervision.

The company sells its products through a combination of direct sales forces, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. With operations in approximately 100 countries, Baxter is a global leader in the healthcare industry.

In addition to its product offerings, Baxter is committed to advancing patient care through research and collaboration. The company has agreements with organizations such as Celerity Pharmaceutical, LLC and Miromatrix Medical Inc. to develop new products and therapies. Founded in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois, and can be found online at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Baxter International (BAX) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Baxter International (BAX) - Stock & Dividends

BAX Stock Overview

Market Cap in USD 16,979m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1981-10-27

BAX Stock Ratings

Growth 5y -57.2
Fundamental -12.5
Dividend 7.20
Rel. Performance vs Sector -3.67
Analysts 3.44/5
Fair Price Momentum 29.18 USD
Fair Price DCF 38.40 USD

BAX Dividends

Yield 12m 3.38%
Yield on Cost 5y 1.55%
Dividends CAGR 5y 6.42%
Payout Consistency 94.3%

BAX Growth Ratios

Growth 12m -21.50%
Growth Correlation 12m -17%
Growth Correlation 3m -77%
CAGR 5y -14.45%
CAGR/Mean DD 5y -0.55
Sharpe Ratio 12m -0.98
Alpha vs SP500 12m -37.32
Beta vs SP500 5y weekly 0.48
ValueRay RSI 61.31
Volatility GJR Garch 1y 30.68%
Price / SMA 50 -4.72%
Price / SMA 200 -7.87%
Current Volume 6949.9k
Average Volume 20d 4894.4k

External Links for BAX Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of BAX stocks?
As of June 22, 2024, the stock is trading at USD 34.29 with a total of 6,949,914 shares traded.
Over the past week, the price has changed by +1.51%, over one month by +0.41%, over three months by -17.66% and over the past year by -21.15%.
What are the forecast for BAX stock price target?
According to ValueRays Forecast Model, BAX Baxter International will be worth about 31.5 in June 2025. The stock is currently trading at 34.29. This means that the stock has a potential downside of -8.11%.
Issuer Forecast Upside
Wallstreet Target Price 42.8 24.7
Analysts Target Price 47.1 37.3
ValueRay Target Price 31.5 -8.11